pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

23,715 catalysts · 18,987 approval · 7,208 phase readout · 5,000 device 510k · 4,728 grant · 3,603 8k filing · 2,000 device pma

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 1 catalyst2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts2026-11-09: 1 catalyst2026-11-10: 0 catalysts2026-11-11: 0 catalysts2026-11-12: 0 catalysts2026-11-13: 0 catalysts2026-11-14: 0 catalysts2026-11-15: 0 catalysts2026-11-16: 0 catalysts2026-11-17: 0 catalysts2026-11-18: 0 catalysts2026-11-19: 0 catalysts2026-11-20: 0 catalysts2026-11-21: 0 catalysts2026-11-22: 0 catalysts
view
agendamonth
hide past →
sort
soonestlatesttypesponsoralpha
type: approval×type: grant×clear all
type
  • approval18,987
  • phase readout7,208
  • device 510k5,000
  • grant4,728
  • 8k filing3,603
  • device pma2,000
  • device recall
2,000
  • recall1,126
  • device adverse event1,000
  • earnings585
  • therapy area

    no tagged catalysts yet

    Week of Mar 9, 2026

    50
    ›Mar 10, 2026grant174d agoWEILL MEDICAL COLL OF CORNELL UNIV — Transcriptional control by autism associated H3K9 methylation regulators duri...

    MH grant. $800,667. PI: Matthias Stadtfeld

    full page →nih reporter ↗
    ›Mar 10, 2026grant174d agoDANA-FARBER CANCER INST — The Fourth International Merkel Cell Carcinoma Symposium

    AR grant. $20,000. PI: Ann W. Silk

    full page →nih reporter ↗
    ›Mar 10, 2026grant174d agoDREXEL UNIVERSITY — Investigating molecular mechanisms of glutamate toxicity in HIV-1 Tat-induced...

    MH grant. $49,416. PI: Brenna Duffy

    full page →nih reporter ↗
    ›Mar 10, 2026grant174d agoDUKE UNIVERSITY — Functions and mechanisms of metalloenzymes in natural product and cofactor bi...Duke University

    GM grant. $737,152. PI: Kenichi Yokoyama

    full page →nih reporter ↗
    ›Mar 10, 2026grant174d agoOHIO STATE UNIVERSITY — Oligosaccharide cross-feeding and competition in microbial communities

    GM grant. $375,898. PI: Darryl A Wesener

    full page →nih reporter ↗
    ›Mar 10, 2026grant174d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Intersectional analysis of the Whole Person Care-Los Angeles social care inte...University of California Los Angeles

    DK grant. $616,107. PI: Sae Takada

    full page →nih reporter ↗
    ›Mar 10, 2026grant174d agoHARVARD UNIVERSITY — Examining the processes that deform bacterial membranes to initiate cell divi...

    GM grant. $1,600,449. PI: Ethan Clark Garner

    full page →nih reporter ↗
    ›Mar 10, 2026grant174d agoVERSITI BLOOD HEALTH, INC. — Decoding kindlin-3 signaling in platelets and neutrophils

    HL grant. $1,069,072. PI: Yan-Qing Ma

    full page →nih reporter ↗
    ›Mar 10, 2026grant174d agoUNIVERSITY OF MISSOURI KANSAS CITY — Addressing Food Access and Physcial Activity to Improve Diabetes Prevention O...

    DK grant. $847,068. PI: JENIFER ELIZABETH ALLSWORTH

    full page →nih reporter ↗
    ›Mar 10, 2026grant174d agoDUKE UNIVERSITY — Real-Time, Longitudinal, Functional Brain Imaging via 4D Smart Epidermal Phot...Duke University

    EB grant. $722,392. PI: Xiaoyue Ni

    full page →nih reporter ↗
    ›Mar 10, 2026grant174d agoGORDON RESEARCH CONFERENCES — 2026 Autophagy in Stress, Development and Disease Gordon Research Conference ...

    CA grant. $4,000. PI: Rushika Miriam Perera

    full page →nih reporter ↗
    ›Mar 11, 2026approval173d agoLABETALOL HYDROCHLORIDE — FDA approvalHikma Pharmaceuticals USA Inc

    Sponsor: HIBROW HLTHCARE. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 11, 2026approval173d agoTESTOSTERONE — FDA approvalTransdermal Delivery Solutions Corp

    Sponsor: ENCUBE. Form: GEL, METERED. Route: TRANSDERMAL

    full page →fda approvals ↗
    ›Mar 11, 2026approval173d agoDOXYCYCLINE — FDA approvaldoxycycline ER

    Sponsor: STRIDES PHARMA INTL. Form: CAPSULE. Route: ORAL

    full page →doxycycline ER →fda approvals ↗
    ›Mar 11, 2026approval173d agoCEVIMELINE HYDROCHLORIDE — FDA approvalCEVIMELINE HYDROCHLORIDE

    Sponsor: ZYDUS LIFESCIENCES. Form: CAPSULE. Route: ORAL

    full page →CEVIMELINE HYDROCHLORIDE →fda approvals ↗
    ›Mar 11, 2026approval173d agoLIRAGLUTIDE — FDA approvalSaxenda

    Sponsor: BIOCON PHARMA. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →Saxenda →fda approvals ↗
    ›Mar 11, 2026approval173d agoOMEPRAZOLE — FDA approvalomeprazole DR

    Sponsor: DEXCEL. Form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE. Route: ORAL

    full page →omeprazole DR →fda approvals ↗
    ›Mar 11, 2026approval173d agoSODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER (SODIUM CHLORIDE) — FDA approvalRevalesio Corp

    Sponsor: LABORATORIOS GRIFOLS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 11, 2026approval173d agoFENOFIBRIC ACID (CHOLINE FENOFIBRATE) — FDA approvalcholine fenofibrate

    Sponsor: ALEMBIC. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

    full page →choline fenofibrate →fda approvals ↗
    ›Mar 11, 2026approval173d agoFENOFIBRIC ACID (CHOLINE FENOFIBRATE) — FDA approvalcholine fenofibrate

    Sponsor: ALEMBIC. Form: CAPSULE, DELAYED RELEASE. Route: ORAL

    full page →choline fenofibrate →fda approvals ↗
    ›Mar 11, 2026approval173d agoOZURDEX (DEXAMETHASONE) — FDA approvaldexamethasone LA

    Sponsor: ABBVIE. Form: IMPLANT. Route: INTRAVITREAL

    full page →dexamethasone LA →fda approvals ↗
    ›Mar 11, 2026approval173d agoLANSOPRAZOLE — FDA approvallansoprazole DR

    Sponsor: DEXCEL. Form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE. Route: ORAL

    full page →lansoprazole DR →fda approvals ↗
    ›Mar 11, 2026approval173d agoFERRIC CITRATE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 11, 2026approval173d agoMEROPENEM — FDA approvalMEROPENEM

    Sponsor: SAVIOR LIFETEC CORP. Form: INJECTABLE. Route: INJECTION

    full page →MEROPENEM →fda approvals ↗
    ›Mar 11, 2026approval173d agoMEROPENEM — FDA approvalMEROPENEM

    Sponsor: SAVIOR LIFETEC CORP. Form: INJECTABLE. Route: INJECTION

    full page →MEROPENEM →fda approvals ↗
    ›Mar 11, 2026approval173d agoMEROPENEM — FDA approvalMEROPENEM

    Sponsor: SAVIOR LIFETEC CORP. Form: INJECTABLE. Route: INJECTION

    full page →MEROPENEM →fda approvals ↗
    ›Mar 11, 2026approval173d agoLINAGLIPTIN AND METFORMIN HYDROCHLORIDE (LINAGLIPTIN) — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 11, 2026approval173d agoAPHEXDA (MOTIXAFORTIDE ACETATE) — FDA approvalBioLineRx Ltd.

    Sponsor: AYRMID PHARMA. Form: POWDER. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Mar 11, 2026approval173d agoBRIMONIDINE TARTRATE — FDA approvalLumify

    Sponsor: GLAND. Form: SOLUTION/DROPS. Route: OPHTHALMIC

    full page →Lumify →fda approvals ↗
    ›Mar 11, 2026grant173d agoLEHIGH UNIVERSITY — 3D-Printed Scaffolds with Independently Tunable Multiscale Properties

    EB grant. $72,965. PI: Lesley W Chow

    full page →nih reporter ↗
    ›Mar 11, 2026grant173d agoDUKE UNIVERSITY — Geriatric oncology assessment to link with support for older women taking adj...Duke University

    CA grant. $668,691. PI: Gretchen Kimmick

    full page →nih reporter ↗
    ›Mar 11, 2026grant173d agoNEW JERSEY INSTITUTE OF TECHNOLOGY — Engineering an in vitro 3D tissue construct to study peripheral nerve regener...

    NS grant. $553,292. PI: Jonathan M. Grasman

    full page →nih reporter ↗
    ›Mar 11, 2026grant173d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Novel Multi-targeted Strategies Targeting T-cell Lymphomas and their Microenv...

    CA grant. $646,920. PI: Ryan A Wilcox

    full page →nih reporter ↗
    ›Mar 11, 2026grant173d agoHARVARD UNIVERSITY D/B/A HARVARD SCHOOL OF PUBLIC HEALTH — Novel Methods for Joint Prediction in the presence of mortality

    HL grant. $43,560. PI: Stephanie Armbruster

    full page →nih reporter ↗
    ›Mar 11, 2026grant173d agoUNIVERSITY OF MISSOURI-COLUMBIA — Multimodal, Porous, Starfish-Like Soft Wearable Bioelectronic Systems for Mot...

    EB grant. $597,977. PI: Zheng Yan

    full page →nih reporter ↗
    ›Mar 11, 2026grant173d agoUTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH — PULSE (Program Understanding and Learning through Strategic Evaluation)University of Utah

    GM grant. $105,987. PI: Janet Iwasa

    full page →nih reporter ↗
    ›Mar 11, 2026grant173d agoLSU PENNINGTON BIOMEDICAL RESEARCH CTR — Breath Biomarkers of Disease and Health Outcomes (BREATHE OUT)

    GM grant. $225,000. PI: Jacob T Mey

    full page →nih reporter ↗
    ›Mar 12, 2026approval172d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

    Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 12, 2026approval172d agoCOSENTYX (SECUKINUMAB) — FDA approvalNOVARTIS AG

    Sponsor: NOVARTIS PHARMS CORP. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 12, 2026approval172d agoPROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE (DEXTROMETHORPHAN HYDROBROMIDE) — FDA approvalPROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE

    Sponsor: HETERO LABS LTD III. Form: SYRUP. Route: ORAL

    full page →PROMETHAZINE HYDROCHLORIDE AND DEXTROMETHORPHAN HYDROBROMIDE →fda approvals ↗
    ›Mar 12, 2026approval172d agoTRULICITY (DULAGLUTIDE) — FDA approvaldulaglutide

    Sponsor: ELI LILLY AND CO. Form: INJECTABLE. Route: INJECTION

    full page →dulaglutide →fda approvals ↗
    ›Mar 12, 2026approval172d agoSOLIQUA 100/33 (INSULIN GLARGINE) — FDA approvalToujeo LA

    Sponsor: SANOFI-AVENTIS US. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →Toujeo LA →fda approvals ↗
    ›Mar 12, 2026approval172d agoPOTASSIUM PHOSPHATES (POTASSIUM PHOSPHATE, DIBASIC) — FDA approvalHospira Inc

    Sponsor: CAPLIN. Form: SOLUTION. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Mar 12, 2026approval172d agoFINGOLIMOD HYDROCHLORIDE — FDA approvalFINGOLIMOD HYDROCHLORIDE

    Sponsor: BIOCON LTD. Form: CAPSULE. Route: ORAL

    full page →FINGOLIMOD HYDROCHLORIDE →fda approvals ↗
    ›Mar 12, 2026approval172d agoFINGOLIMOD HYDROCHLORIDE — FDA approvalFINGOLIMOD HYDROCHLORIDE

    Sponsor: BIOCON LTD. Form: CAPSULE. Route: ORAL

    full page →FINGOLIMOD HYDROCHLORIDE →fda approvals ↗
    ›Mar 12, 2026approval172d agoADLYXIN (LIXISENATIDE) — FDA approvalADLYXIN

    Sponsor: SANOFI-AVENTIS US. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →ADLYXIN →fda approvals ↗
    ›Mar 12, 2026approval172d agoSUNLENCA (LENACAPAVIR SODIUM) — FDA approvallenacapavir sodium LA

    Sponsor: GILEAD SCIENCES INC. Form: SOLUTION. Route: SUBCUTANEOUS

    full page →lenacapavir sodium LA →fda approvals ↗
    ›Mar 12, 2026approval172d agoSUNLENCA (LENACAPAVIR SODIUM) — FDA approvallenacapavir sodium LA

    Sponsor: GILEAD SCIENCES INC. Form: TABLET. Route: ORAL

    full page →lenacapavir sodium LA →fda approvals ↗
    ›Mar 12, 2026approval172d agoPOMALIDOMIDE — FDA approvalTeva Pharmaceuticals USA Inc

    Sponsor: TEVA PHARMS USA. Form: CAPSULE. Route: ORAL

    full page →fda approvals ↗
    ›Mar 12, 2026grant172d agoTUFTS UNIVERSITY BOSTON — Role of adipocyte interferon regulatory factor 8 in adipocyte and systemic me...

    DK grant. $232,000. PI: ANDREW S GREENBERG

    full page →nih reporter ↗
    ← prev
    page 446 of 475
    next →
    $NVS153.81-0.54%
    $NVS153.81-0.54%
    $GILD145.68-2.14%
    $BLRX2.6000-8.77%
    $GILD145.68-2.14%
    $LLY1174.61-0.13%
    $ABBV255.48-1.03%